Special operations veterans suffering from traumatic brain injury and post-traumatic stress disorder experienced significant improvement in symptoms after a single dose of the psychoactive drug ibogaine. Brain scans revealed that the treatment was associated with a sustained increase in cerebral blood flow and extensive reorganization of neural networks. The study was published in the journal Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
Sudden blows to the head or exposure to intense blast waves can cause traumatic brain injuries. In combat zones, soldiers are exposed to blast waves that send immense pressure on their skulls, potentially stretching or severing delicate nerve fibers. Chronic effects include severe anxiety, depression, and decreased ability to perform daily tasks.
In special operations, veterans experience brain injuries and stress disorders at incredibly high rates compared to civilians. Standard treatment relies heavily on regular talk therapy and symptom management medications. Many veterans are unable to obtain relief through these traditional channels.
To help ex-service members regain independence, health organizations are actively exploring new approaches to restorative care. Derived from a shrub native to central Africa, ibogaine is a naturally occurring psychedelic compound. This substance has a long history of use in spiritual rituals by Gabon’s Bwiti religion.
In recent years, researchers have analyzed the drug as a potential treatment for addiction and mental illness. This is a very active area of research as psychologists seek alternative drugs for treatment-resistant patients. Once in the body, ibogaine is rapidly converted into active byproducts that remain for long periods of time.
This secondary chemical bombards the brain with small proteins over several days. These specific proteins help organs build new nerve connections and repair damaged tissue. This physical restructuring process is known to scientists as neuroplasticity.
Severe impacts to the head often damage blood vessels, significantly reducing the local energy supply throughout the cortex. Starvation at the cellular level often leads to cognitive decline long before physical tissue loss becomes apparent on standard medical scans. Reversing this reduction in blood supply is a major physiological goal for restoring a healthy mind after physical injury.
Lead authors Malvika Sridhar and Azeezat Azeez, along with senior authors Manish Sagar and Nolan R. Williams of Stanford University, wanted to understand how this medicinal compound physically changes the human brain. They build on previous trials in which veterans showed remarkable clinical improvement after receiving ibogaine in combination with intravenous magnesium.
Magnesium was included to protect the cardiovascular system from the rhythm risks commonly associated with psychedelics. Veterans reported feeling much better mentally and physically after the experimental treatment, but the underlying brain changes remained a mystery.
To understand the biological mechanisms, the research team followed 30 male veterans who voluntarily enrolled at a clinic in Mexico. All participants had sustained mild to moderate head injuries. Most of the veterans also met diagnostic criteria for severe post-traumatic stress disorder.
The researchers used functional magnetic resonance imaging to take detailed pictures of the participants’ brains. Participants were scanned at three different time points. The first scan was performed before starting treatment to establish a biological baseline.
A second brain scan was conducted immediately after the medication session ended. A final scan was performed after a full month to examine any lasting physiological effects. The overall image processing utilized two different tracking techniques to map brain activity.
One scanning method tracked the flow of newly oxygenated blood through the brain’s complex blood vessels. The scientists accomplished this by magnetically tagging water molecules in the blood just before they reach the skull. Active brain cells require more oxygen, making local blood flow a reliable indicator of healthy brain function.
The second imaging method measured how different regions of the organ communicate with each other. This was recorded while the veterans were quietly resting and staring blankly at the screen. When one region of the brain consistently consumes oxygen at exactly the same rhythm as a distant region, scientists assume that the two regions are connected in a functional network.
Blood flow measurements provided evidence of sustained metabolic changes. After one month of treatment, the veterans showed a gradual increase in blood flow in several key areas of the brain. The increase was particularly concentrated in the cortex, striatum, and limbic system.
The limbic system is an inner circle of brain tissue deeply involved in emotional processing and memory formation. These psychological functions are frequently disrupted by combat-related head trauma. Metabolic changes suggested a return to a healthier neurological state.
Specific spikes in blood flow were found in the anterior cingulate cortex and left insular cortex. The insular cortex helps individuals process their internal physical states and plays an important role in an individual’s motivation. Increased blood flow in these two areas directly corresponded to improvements in daily living that the veterans reported.
Psychologists quantified these improvements using an extensive symptom questionnaire designed by the World Health Organization. Veterans who had the most blood flow to the insula experienced the greatest functional recovery. They reported that physical mobility and normal home life activities became easier.
The researchers also observed extensive reorganization of functional brain networks. After a single dose of ibogaine, communication patterns between different brain regions changed significantly. This change spread throughout the networks responsible for attention, sensory processing, and wasted thinking.
A significant decrease in connectivity between the amygdala and medial prefrontal cortex was observed. The amygdala functions as the emotional core and fear center of the brain. In people traumatized by combat, hyperconnectivity between the amygdala and prefrontal cortex is associated with emotional dysregulation.
This experimental treatment appears to have the potential to weaken this reactive circuit and reduce the severe emotional response to bad memories. Another connectivity change occurred between the hippocampus and the dorsal attention network.
The hippocampus regulates memory consolidation, and dorsal attention networks help maintain focused goals. Trauma typically impairs both memory retention and cognitive focus. New communication pathways between these regions remained stable for a full month after clinical treatment.
Other changes appeared throughout the organ’s sensory processing areas. More blood flow entered the putamen, an area that affects motor control and language. The saliency network, responsible for filtering important emotional stimuli from background noise, was also characterized by changing connectivity.
The broader neuroscience community hypothesizes that psychedelic compounds relax the brain’s rigid control systems. Under this theoretical model, deeply ingrained thought patterns are temporarily loosened. This release allows the brain to process old trauma from a flexible perspective, potentially explaining the widespread network reorganization seen in the data.
Although this study opens the door to deeper neurobiological research, it has clear limitations. The sample size was relatively small and consisted entirely of middle-aged male veterans. The lack of diversity means that the findings may not apply to the general population or individuals who have sustained different types of head injuries.
The trial was observational and did not include a protective placebo component. All participants knew they were taking the active ingredient, which may influence how they report symptoms. Veterans also sustain multiple brain injuries during combat, complicating efforts to pinpoint the physical cause of their trauma.
More participants and strict control groups are needed to further evaluate these results. To verify these initial observations, scientists will need to evaluate patients given an inert placebo alongside those given the actual treatment. In the meantime, these early scans will provide a basic map of how ibogaine changes the brains of severely injured humans.
The study, “Neural Correlates of Ibogaine: Evidence from Functional Neuroimaging in Veterans,” was authored by Malvika Sridhar, Azeezat Azeez, Andrew D. Geoly, Jennifer I. Lissemore, Afik Faerman, Kirsten Cherian, Derrick M. Buchanan, Saron Hunegnaw, Jackob N. Keynan, and Ian H. Kratter. Cammy Rolle, Manish Sagar, Nolan R. Williams.
